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1. Introduction 
Human placenta maintains pregnancy. The mitochondria of this tissue synthesize 
pregnenolone (P5) from cholesterol through a transport chain formed by adrenodoxin, 
adrenodoxin reductase and cytochrome P450scc (CYP11A1; EC 1.14.15.6) , which breaks up 
the lateral chain of cholesterol. P5 is transformed into progesterone (P4) within 
mitochondria by the 3-OH-steroid-dehydrogenase-5-6isomerase (3HSD). The particular 
hormone(s) or substance(s) that modulate P4 synthesis during pregnancy is currently 
unknown (Strauss et al., 1996; Martinez & Strauss, 1997); nevertheless, the presence of cAMP 
analogues stimulated P4 synthesis in trophoblastic cells, suggesting that a hormonal signal 
or another kind of signal may modulate the concentration of this second messenger into the 
cells (Ringler et al., 1989; Strauss et al., 1992). Although P4 synthesis was suggested to be the 
main function of the placenta, the analysis of P450scc cytochrome concentration shows that 
placental mitochondria have a lower content of P450scc than respiratory chain cytochromes 
(Table 1), even when it is compared to adrenal gland mitochondria, suggesting that 
placental mitochondria participate in other functions different to that from steroidogenesis. 
 
 Human Placenta Adrenal Glands 
Cytochrome nmol/mg  
of mitochondrial protein 
nmol/mg  
of mitochondrial protein 
a1 + a3 0.140 0.10 - 0.23 0.75   
b 0.089 0.07 - 0.17 0.32   
c + c1 0.125 0.13  0.29 0.67   
P450scc 0.110 0.10 0.123 1.50 1.30 0.39 1.0 
Reference Négrié et 
al., 1979
Simpson 
& Miller, 
1978 
Meigs & 
Ryan, 1968 
Cammer 
& 
Estabrook, 
1967 
Harding 
& Nelson, 
1966 
I. Hanukoglu 
& Z. 
Hanukoglu, 
1986 
Jefcoate 
et al., 
1973 
Table 1. Concentration of cytochromes in human placenta and adrenal gland mitochondria 
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It seems that ATP synthesis in placental mitochondria is not related to its consumption at 
the cytoplasm, but rather it is related to the mitochondrial metabolism and, although 
seemingly contradictory, this allows pregnancy to reach full-term delivery. 
2. Transport  
2.1 Transport of carbohydrates, lipids, and amino acids 
The development of both placenta and fetus is metabolically related. The mother supplies 
the essential nutrients for the fetus and the placenta, and their transport is strictly controlled 
in the placenta by the expression and the activity of specific transporters in the plasma 
membrane of syncytiotrophoblast (Angiolini et al., 2006). When the development of the 
fetus is optimal, some transporters of nutrients and ions are downregulated in the placenta; 
then a decrease of cellular receptors for specific molecules is observed (Hahn et al., 1999). 
The placenta uses mainly glucose for its metabolism and at the same time transports it to the 
fetus that requires 4-8 mg/kg/min of glucose for the oxidative phosphorylation (OXPHOS) 
process (Aldoreta & Hay, 1995). Two isoforms of GLUT have been identified: GLUT1 and 
GLUT3 (Kahn & Flier, 1990). GLUT 1 is responsible of glucose uptake from the maternal 
circulation and its activity is independent of insulin. Glucose itself down-regulates the 
placental GLUT1 providing a fetal protection mechanism when maternal glucose is high 
(Hahn, 1998). GLUT3 is relevant during implantation and establishment of the placenta, and 
thereafter GLUT3 is not required; suggesting that GLUT3 has no relevance in glucose 
uptake after the first trimester (Clarson et al., 1997). 
Glucose placental transport is accomplished by facilitated diffusion through GLUT1 
transporter, but its expression is not affected by the concentration of extracellular glucose 
(3.7 mM o 70 mg/dl maternal and 3.2 mM o 61 mg/dl fetal) (Ingermann, 1987). It has been 
reported that the placenta is in constant hypoxia, for which it has a glycolytic metabolism, 
where 70% of total glucose is used to produce ATP through anaerobic glycolysis (Hanguel et 
al., 1986).  
Glycogen is synthesized by the human placenta only as a primary response to maternal 
hyperglycemia. Although glycogen during pregnancy has been reported (Ville, 1953), the 
placenta does not synthesize glycogen efficiently (Barash et al., 1991). There are data 
showing the presence of gluconeogenic enzymes (Matalon & Michals, 1984), and 
Prendergast et al. demonstrate that the placenta synthesizes glucose, and evidence of the 
presence of glucose-6-phosphatase has been published (Matsubara et al., 1999; Prendergast 
et al., 1999); however, it is unknown whether the glucose synthesis might have any 
physiologic relevance. 
The incubation of trophoblastic cells, perfused explants or placentas, produces lactic acid as 
a result of anaerobic glycolysis used by the fetus (Battaglia, 1989; Piquard et al., 1990). The 
radioactivity of glucose labeled with 14C showed the following distribution: lactate 60-69%, 
glycogen 1.3-4.8%, pentose pathway 5%, fatty acids 0.7-1.4% and CO2 1.6-2.4% (Desoye & 
Shafrir, 1994). Similarly, in slices of human placenta from middle gestation, 73% of glucose 
was degraded through glycolysis, 10% through pentose pathway and the rest through lipids 
formation and glycogen synthesis. Although pentose pathway has been described in the 
placenta (Shelley, 1979), reports suggest that it does not make an important contribution to 
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glucose metabolism (Moe et al., 1991). The placenta can also use fructose or lactate as energy 
sources. 
 
Condition Glucose consumption Lactate production 
 mmol/h/g 
95% O2 + 5% CO2 6.96 ± 2.50 21.23 ± 7.79 
95% N2 + 5% CO2 12.50 ± 3.36 24.06 ± 5.24 
Table 2. Glucose consumption and lactate production in human placenta (Modified from 
Schneider et al., 1988). 
The placenta transports 50% of fatty acids to the fetus during the last trimester of pregnancy; 
that is the reason why -oxidation is not a good candidate for ATP generation. In addition, 
placental membranes have a lipoprotein lipase which catalyzes the degradation of 
lipoproteins, mainly VLDL (Coleman, 1986). Fatty acids and glycerol are transported by 
simple diffusion and, once inside the trophoblast, they are bound to proteins and are 
transported to the basal stratus to diffuse to the fetus. 
The following proteins have been related to the transport of lipids, the plasma membrane 
fatty acid binding protein (pFABPpm), fatty acid transporter protein (FATP) and the 
cytoplasmic fatty acid binding protein family (FABP) (Hornstra et al., 1995). pFABPpm 
makes up about 4% of cytosolic proteins, it is responsible for the intracellular 
distribution of fatty acids and to the membrane, and mainly binds essential long chain 
fatty acids. Also, the transport of essential fatty acids by the placenta is important, since 
these acids are implicated in cell-cell signaling and contribute to the development of the 
fetal brain, as well as cardiovascular and lung development (Wollet, 2005; Cunningham et 
al., 2009).  
Cholesterol is the precursor of steroid hormones but it is not synthesized by the human 
placenta. Trophoblast cells express receptors for lipoproteins like LDL, VLDL, and class A 
scavenger receptors, as well as for the LDL receptor-related protein (LRP), the 
apolipoprotein E (apoE) receptor 2, and the scavenger receptor class B type (SR-BI). The 
cholesterol required for the synthesis of P4 is provided by maternal lipoproteins (Strauss et 
al., 1996; Palinski, 2009) (Fig.1).  
Protein synthesis is essential for fetal development; the human placenta has at least three 
different amino acid transporters (neutral, cationic and anionic) coupled to an ionic energy 
dependent process. Two cationic amino acid transporter systems called y+ (Hoeltzli  
Smith, 1989) and y+L (Fei et al., 1995) are specific for cationic amino acids and are widely 
expressed in both maternal and fetal sides. System “y” is Na+-independent (Moe, 1995) and 
system y+L has higher affinity for lysine and neutral amino acids. Transport of neutral 
amino acids involves the transporters A, ASC and L. Type A is a Na+-dependent transporter 
with affinity for amino acids with short polar or linear side chains. System ASC is a Na+-
dependent transport for serine, cysteine, threonine and glutamine. The system L is a Na+ 
independent transporter for large aromatic or non-polar branched side chains of amino 
acids (Yudilevich   Sweiry, 1985).  
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Fig. 1 Maternal-fetal cholesterol transport in the placenta (Modified from Palinski, 2009). 
2.2 Transport of relevant ions   
Ions are needed for fetus growth and metabolism, due to their contribution to cell 
homeostasis. The ions are not only related to amino acid transport, because ion transporters 
are necessary for other cellular functions. Na+ is transported actively (Stulc et al., 1995). 
Carter has reported that 30% of the ATP produced by the placenta is used for the synthesis 
of proteins and steroids; while Na+/K+ ATPase consumes another 20-30%, making these 
processes the most costly and the main consumers of placental energy (Carter, 2000). 
Chloride is co-transported with Na+ or K+; it is bidirectional and almost symmetrical and 
apparently associated with the maintenance of cell volume. Calcium is transported to the 
fetus against a concentration gradient reaching a fetal plasma concentration higher than 
maternal plasma concentration (Stulc, 1997). 
Potassium is taken by the Na+-K+-ATPase and its efflux through the K+-channel (KATP); the 
fetal transport of K+ is against a concentration gradient and independent of the maternal 
potassium status (Stulc, 1997). 
The movement of ions in the cell has relevance in the mitochondrial metabolism; the 
increase of K+ in the cytoplasm in adrenal cells stimulates aldosterone synthesis (Spät  
Pitter, 2004). The mechanism involves the release of Ca2+ from its cellular reservoirs 
modifying the mitochondria metabolism. Human placental mitochondria have a vectorial 
influx of Ca2+, and changes in its concentration modifies P4 synthesis (García-Pérez et al., 
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2002), although this transport can be modified by K+. It has been observed that the increases 
of K+ also modify mitochondrial steroidogenesis (Martinez, 1995). The transport of K+ in the 
mitochondria has not been clarified, but it has been proposed that it could be through the 
mitoKATP channel described by Garlid (Garlid  Paucek, 2003). 
3. Energetic metabolism 
3.1 Architecture of the human placental mitochondria  
The size, aspect and organization of mitochondrial membranes vary between species, tissues 
and physiological conditions. Using isolated mitochondria and cultured cells, Hackenbrock 
revealed a close coupling between ultrastructure and energetic state (Hackenbrock et al., 
1971). In the energized state, when low ADP concentrations are limited for OXPHOS (the so-
called respiratory state IV), mitochondria display the common, orthodox conformation: 
filamentous electron-dense cristae within a matrix of intermediate electron density. When 
high ADP concentrations accelerate OXPHOS (the respiratory state III), mitochondria adopt 
the condensed conformation: the matrix is condensed and electron dense, while the 
intermembrane space and cristae-lumen appears swollen and electron light. Reversible 
changes between the orthodox and condensed conformation are modulated by metabolites, 
by drugs that inhibit respiratory complexes or by ionophores that uncouple respiration and 
phosphorylation (Hackenbrock, 1968, 1971). Decades ago, several authors confirmed that 
stimulation of respiration induces the condensed conformation, with a characteristic 
electron-dense matrix in mitochondria (Malka et al., 2005; Rossignol et al., 2004). It is 
reasonable to assume that mitochondrial ultrastructure, morphology and dynamics are 
linked and thus, that mitochondrial morphology and dynamics are also modulated by 
OXPHOS. 
Although many types of mitochondrial cristae structure have been described (Munn, 1974), 
from recent electron microscopic tomography studies, the differences between typical 
mitochondria are now evident; e.g., liver (Mannella, 1994, 1997), neuronal (Perkins, 1997, 
2001a), brown adipose tissue (Perkins et al., 1998), fungus (Nicastro et al., 2000; Perkins et 
al., 2001b),  rods and cones (Perkins, 2003), and those from steroidogenic tissues, e.g., Leydig 
cells (Prince, 2002). In general, cristae from typical mitochondria are lamellar while in 
steroidogenic cells are tubular, vesicular, or tubulovesicular (Reichert et al., 2002). It has 
been suggested that due to this particular morphology of the cristae, mitochondria of Leydig 
cells should not be able to produce ATP, since the narrow gap between lamellae would not 
allow the location of the F1 subunit of ATP synthase (Prince, 2002); however, a recent 
publication indicates that mitochondrial membrane potential (m), mitochondrial ATP 
synthesis, and mitochondrial respiration are all required to support Leydig cell 
steroidogenesis (Allen et al., 2006). 
In our laboratory, two kinds of mitochondria were isolated from human placenta: non 
steroidogenic mitochondria with typical cristae from cytotrophoblast, and steroidogenic 
mitochondria with vesicular cristae from syncytiotrophoblast. In situ, large mitochondria 
were observed in cytotrophoblast cells, with morphology similar to the typical liver 
mitochondria, and containing lamellar cristae in an orthodox configuration (Fig. 2). In 
contrast, the syncytiotrophoblast contains smaller mitochondria with a condensed matrix 
and cristae composed by vesicular regions connected by narrow tubules. The larger 
cytotrophoblast mitochondria have a round shape, whereas syncytiotrophoblast 
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mitochondria display an irregular shape with protuberances of the outer and inner 
membranes (De Los Rios Castillo et al., 2011). 
 
Fig. 2. Ultrastructure of human syncytiotrophoblast and cytotrophoblast cells. (A) Electron 
micrograph of term placenta villus showing syncytiotrophoblast and underlying 
cytotrophoblast. N, nucleus; M, mitochondria. 10,000 X. (B) Isolated mitochondria from 
human cytotrophoblast and syncytiotrophoblast. Scale bar, 200 nm (Modified from De Los 
Rios Castillo et al., 2011) 
Isolated cytotrophoblast and syncytiotrophoblast mitochondria showed values for 
respiratory control higher than those previously reported for this tissue (Olivera & Meigs, 
1975)  and the oxygen uptake was coupled to ATP synthesis, reaching 151 ± 16 and 153 ± 13 
nmol ATP/mg/min, respectively (De Los Rios Castillo et al., 2011). These observations 
demonstrate the presence of functional mitochondria in both cell types, retaining the ability 
to increase the consumption of oxygen and the synthesis of ATP upon the addition of ADP. 
3.2 Energetic pathways 
The metabolism of mitochondria involves two major pathways: energy production and P4 
synthesis, and several evidences show that both are closely related, as suggested by the 
similar content of cytochromes from the electron transport chain cytochrome P450scc, 
suggesting the alternating activity of both pathways, which can generate ATP for cell 
function and for P4 synthesis to maintain pregnancy. A mechanism to regulate the 
functioning of both pathways could be the presence of alternative enzymes, e.g. an NADP-
dependent isocitrate dehydrogenase is associated to the inner mitochondrial membrane; 
isocitrate, the substrate for this enzyme supports progesterone synthesis, while succinate 
promotes the synthesis of ATP. 
It has been described that ATP-diphosphohydrolase and ADPase enzymes are tightly bound 
to mitochondrial membranes and their activities are involved in steroidogenesis. Particularly, 
the activity of ATP-diphosphohydrolase was described as supporting P4 synthesis, probably 
providing the energy requirement for cholesterol transport between the mitochondrial 
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membranes, similar to the activity of mitochondrial GDPase reported in adrenal gland (Fig. 3) 
Additionally, these enzymes could participate in the transformation of ATP to adenosine, 
which can be released into the blood vessels to promote oxygenation of the placenta. 
 
Fig. 3. Effect of several nucleotides on progesterone synthesis and their hydrolysis by 
human placental apyrase. Mitochondria were incubated in progesterone synthesis medium 
with or without 1 mM 5’p-fluorsulfonyl benzoyl adenosine (FSBA). Nucleotide hydrolysis 
was also performed in progesterone synthesis medium.  Progesterone synthesis (□); 
nucleotide hydrolysis (■); progesterone synthesis + FSBA (▓); nucleotide hydrolysis + FSBA 
(░) (Modified from Flores-Herrera et al., 2002). 
The concentration of adenine nucleotides is another way to analyze the pathways that 
produce energy in the form of ATP. The total amount of nucleotides at the time of expelling 
is 0.766 a 0.816 mmol/g wet weight, ATP 0.49, ADP 0.23, and AMP 0.12 nmol/g wet weight 
(Young & Schneider, 1984). In mitochondria isolated from full-term human placenta the 
concentrations of nucleotides are 1.24 5.78 y 1.09 nmol of ATP, ADP, and AMP/mg of 
protein, respectively (Martinez et al., 1987). These data suggest that in spite of the anoxia 
produced by labor, the placenta synthesizes mainly ATP, whereas glycogen levels do not 
vary significantly until 60 minutes after labor (Bloxam & Bobinski, 1984). The fact that 
mitochondria synthesize ATP does not imply that they supply the trophoblast with ATP for 
its cellular functioning in an important amount.  
3.3 The relevance of nucleotide hydrolysis 
With regard to their steroidogenic role, syncytiotrophoblast mitochondria synthesize P4 
(35.7 ± 0.9 ng P4/mg/min) due to the presence of 3HSD in their inner membrane (Cherradi 
et al., 1994; Martinez et al., 1997; Brand et al., 1998). Their steroidogenic activity was ten 
times higher than cytotrophoblast mitochondria (3.6 ± 1.34 ng P4/mg/min). In both cases, 
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22(R)-hydroxycholesterol, a soluble substrate used to assess maximal steroidogenesis 
(Tuckey, 1992) increased steroidogenic activity to 92.2 ± 3.4 and 10.1 ± 3.95 ng P4/mg/h in 
syncytiotrophoblast and cytotrophoblast mitochondria, respectively (De Los Rios Castillo et 
al., 2011). Additionally we demonstrated that ATP is essential for progesterone synthesis 
(Flores-Herrera et al., 2002). These results agree with the specialized role of each placental 
cell (Martinez et al., 1997) and demonstrate that isolated mitochondria from 
syncytiotrophoblast are intact and retain their physiological function. 
Nevertheless, human syncytiotrophoblast mitochondria have bioenergetics and steroidogenic 
functions, which raise an interesting question: why do they have an irregular shape with 
tubular, vesicular, or tubulovesicular cristae? At present, there is interest concerning proteins 
that govern mitochondrial ultrastructure, but few of such proteins have been identified 
(Pellegrini & Scorrano, 2007). It has been speculated that the dimer of F0F1-ATP synthase 
(complex V for oxidative phosphorylation of ATP) may play a major role in determining 
cristae formation (Paumard et al., 2002; Minauro-Sanmiguel et al., 2005; Dudkina et al., 2005; 
Strauss et al., 2008). Dimerization of F0F1-ATP synthase in the mitochondrial inner 
membrane has been described in yeast (Arnold et al., 1998) and bovine mitochondria 
(Schägger & Pfeiffer, 2000). A critical role in the stability of the mammalian dimeric complex 
V has been proposed for the inhibitory F1 moiety protein (IF1) (García et al., 2006). IF1 is 
known to dimerize in solution (Gordon-Smith et al., 2001), and this dimer has been recently 
shown to interact with two molecules of soluble F1 simultaneously (Cabezón et al., 2000; 
Dominguez-Ramirez et al., 2001). If the same interaction occurs in the membrane, it might 
be responsible for the dimerization of the F0F1-ATP synthase complex, and in mammalian 
cells, changes in IF1 concentration affect the degree of F0F1-ATP synthase dimerization, 
which in turn could alter the formation of cristae (García et al., 2006). In this sense, the 
density of mitochondrial cristae in HeLa cells is increased by IF1 overexpression and 
decreased by IF1 suppression (Campanella et al., 2008); interestingly, IF1 overexpression 
increases both the formation of dimeric F0F1-ATP synthase and F0F1-ATP synthase activity 
(Campanella et al., 2008). 
The analysis of the electron transport chain and oxidative phosphorylation complexes from 
human syncytiotrophoblast and cytotrophoblast mitochondria allow us to demonstrate that 
the dimeric form of the F0F1-ATP synthase (complex V) is involved in the cristae architecture 
in trophoblast cells (De Los Rios Castillo et al., 2011). In this sense, we found that the dimer 
of mitochondrial F0F1-ATP synthase is scarce in syncytiotrophoblast associated to a low IF1 
concentration. Due to the fact that human placenta cells are ontogenetically related, i.e. 
cytotrophoblast cells differentiate into syncytiotrophoblast cells, the amounts of IF1 found in 
the steroidogenic cells could be the result of cell differentiation and have a significant effect 
on their mitochondrial architecture (tubulovesicular cristae) and physiology (P4 synthesis). 
The amount of IF1 and F0F1-ATP synthase dimer present in these mitochondria is probably 
related to its physiological functions. 
But, why do syncytiotrophoblast cells have mitochondria with atypical cristae morphology? 
Since the human placenta does not express StAR (Tuckey, 2005) and TSPO (Maldonado-
Mercado et al., 2008), two proteins involved in mitochondrial cholesterol flow, it has been 
suggested that the reduction in the size of syncytiotrophoblast mitochondria and the change 
in the structure of cristae may improve the steroidogenic activity of syncytiotrophoblast 
cells (Martinez et al., 1997). In this sense, the translocation of cholesterol to P450scc has been 
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well known to be the rate-limiting step in steroidogenesis; thus, a greater surface could 
enhance the movement of cholesterol to the inner membrane where P450scc is located. It is 
tempting to speculate that the non-ortodox cristae structure in mitochondria from 
steroidogenic tissue allows cholesterol to flow from the outer to the inner mitochondrial 
membranes and improves hormone production.  
3.4 Mitochondrial accessory proteins involved in progesterone synthesis 
For P4 synthesis by human syncytiotrophoblast mitochondria, the cristae architecture could 
not be considered as the only and most important issue; we have identified a set of different 
proteins involved in hormone production as a heat shock protein-60 kDa (HSP60), associated 
to the increases of progesterone synthesis through its association with the MLN64-like protein 
(Olvera-Sanchez et al., 2011); an ADPase, and an ATP-diphosphohydrolase associated to 
mitochondrial membranes (Uribe et al., 1999; Flores-Herrera et al., 1999). 
ATP-diphosphohydrolase is anchored to mitochondrial membranes whit its nucleotide-
hydrolyzing activity oriented to the intermembrane space. The kinetic characterization of 
its activity in a detergent solubilized fraction revealed that it can use ATP, ADP, GTP, 
GDP, UTP, UDP, CTP, CDP, TTP and TDP in a cation (Mg+2, Ca+2, and Zn+2) dependent 
fashion as substrates (Flores-Herrera et al., 1999) (Fig. 4). ATP hydrolysis by this ATP-
diphosphohydrolase can stimulate oxygen uptake in intact mitochondria from 
syncytiotrophoblast coupling with ATP synthesis (Martinez et al., 1993). Since one main 
function of mitochondria is the synthesis of ATP through the F0F1-ATPase activity, the 
presence of external mitochondria ATP-diphosphohydrolase and an ADPase in the human  
 
Fig. 4. Effect of 22(R)-hydroxycholesterol (22-OH-Chol) on progesterone synthesis. 
Mitochondria were incubated in progesterone synthesis medium with or without 1 mM 
FSBA. Where indicated, 1 mM ATP or 15 M 22-OH-Chol was added. 100% progesterone 
synthesis = 142 ng progesterone/mg/min (Modified from Flores-Herrera et al., 2002). 
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placental mitochondria could produce a futile cycle due to the combination of the F0F1-
ATPase and ATP-diphosphohydrolase activities, being lethal for trophoblast cells. However, 
the futile cycle is not observed, because the addition of ATP (or ADP) to isolated 
mitochondria induces oxygen consumption without uncoupling the respiration, suggesting 
the presence of mechanisms that regulate the activity of ATP-diphosphohydrolase in a way 
that trophoblast cells remain alive (Martinez et al., 1993). Indeed, ATP-diphosphohydrolase 
activity and its substrate specificity seem to be regulated by the proton electrochemical 
potential (H+), i.e. if mitochondrial inner membrane is energized, ATP-diphosphohydrolase 
selectively hydrolyzes ATP, while dissipation of H+ by CCCP produces a loss of substrate 
specificity, and is able to hydrolyze ATP and GTP equally (O. Flores-Herrera, et al., 
manuscript in preparation). 
With respect to ATP-diphosphohydrolase role in syncytiotrophoblast mitochondria 
steroidogenesis, its activity in presence of ATP is involved in cholesterol transport between 
mitochondrial membranes (Flores-Herrera et al., 1999; Flores-Herrera et al., 2002). In addition, 
other nucleotide hydrolase activities have been determined in mitochondria from other 
steroidogenic tissues; in particular, in adrenal mitochondria GTP enhances steroidogenesis, a 
process modulated by a GTPase (X. Xu & T. Xu, 1989); however, no conclusion can be drawn 
yet in this steroidogenic tissue. However, syncytiotrophoblast mitochondria hydrolyze several 
nucleosides tri- and di-phosphatides increasing P4 synthesis, which is sensitive to ATP-
diphosphohydrolase inhibition by FSBA, a non-hydrolysable ATP analog (Flores-Herrera et 
al., 2002) (Fig. 4). Finally, although the mechanisms of regulation of this enzyme have to be 
elucidated, we conclude that ATP-diphosphohydrolase is anchored to syncytiotrophoblast 
mitochondrial membranes, which nucleotide hydrolysis activity is involved in cholesterol 
transport between mitochondrial membranes and in oxygen uptake by mitochondrial electron 
transport chain (Flores-Herrera et al., 2002). 
4. Signaling pathway in placental steroidogenesis 
4.1 The role of mitochondria in the phosphorylation cell signaling 
Progesterone synthesis by human placenta is essential for the maintenance of pregnancy. In 
the human being, P4 is produced in the corpus luteum cells during the secretory phase of 
the menstrual cycle; whereas in the early stages of pregnancy its production continues due 
to the stimulus of the Chorionic Gonadotropin hormone (hCG); however, between the 6th 
and 8th week of gestation, the corpus luteum decreases its production of P4, which is now 
synthesized by the trophoblastic cells of the placenta (Tuckey, 2005).  
Unlike the other steroidogenic tissues, placental steroidogenesis is chronically regulated. 
Both regulation systems are under the control of diverse factors or hormones that activate 
signal transduction pathways in different forms, allowing either short-term or long-term 
regulation. In general, the chronic response is started within hours after the initiating 
stimulus and involves the activation of certain signaling pathways, among them the cAMP-
dependent protein kinase (PKA) cascade is the most important. 
The effect mediated by PKA/cAMP in long-term and short-term regulation of 
steroidogenesis is the main pathway stimulated by trophic hormones which acts through G 
protein-coupled receptors, which in turn activates the enzyme adenylate cyclase, which 
increases the content of cAMP. cAMP has pleiotropic effects such as the activation of PKA, 
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which phosphorylates proteins and transcription factors such as the steroidogenic factor 
(SF-1) and the protein cAMP response element binding (CREB), the latter being the main 
mediator of positive changes in gene expression (Sands, 2008); for example, the activation of 
StAR gene (Stocco et al., 2005) or even its phosphorylation (Fig. 5). 
 
Fig. 5. The model illustrates the activation of the transduction pathway mediated by 
PKA/cAMP in the postranscriptional and postranslational regulation StAR protein 
(Modified from Manna, 2009). 
Although other PKA-dependent and –independent signaling pathways have been reported, 
the responses generated are generally less potent than those mediated by PKA/cAMP 
(Manna et al., 2006). 
During pregnancy, the production of P4 gradually increases with no substantial variations 
observed (Tuckey, 2005). It has been reported that a plasmatic decrease of P4 is associated 
with a higher probability of abortion (Duan et al., 2010).  
The addition of 8Br-cAMP or dibutyryl-cAMP to cultured trophoblast cells stimulated the 
P4 synthesis by increasing the transcription and translation of P450scc and adrenodoxin. 
Nevertheless, independent of the factors involved modulating the intracellular 
concentration of cAMP, the likely participation of different hormones and the trophic factors 
and cytokines that could have endocrine, paracrine, autocrine or intracrine effect in the 
regulation of steroidogenesis through the signaling pathway mediated by PKA is still 
unknown; since, as it has been said, there are other pathways that can participate in the 
regulation of P4 synthesis (Manna et al., 2006; Stocco et al., 2005) (Fig. 6). 
In trophoblast choriocarcinoma-derived cells of human placenta (BeWo) the addition of 
hCG increased P4 synthesis through PKA. Other factors also increased in a variable way the 
production of P4; nevertheless, it has been suggested that its main effect would be 
predominantly as a regulator and just in a few cases as a stimulant of steroidogenesis, 
although through the activation of cAMP-dependent pathways and PKA activation (Manna 
et al., 2006).  
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Fig. 6. Model proposed to illustrate the cAMP-dependent and –independent pathways in the 
regulation of StAR expression and steroidogenesis in adrenal gland and gonads (Modified 
from Manna, 2009).  
Although the signaling pathways associated with P4 synthesis in human placenta are 
unknown, one of the best studied mechanism is the one mediated by PKA activation. Unlike 
gonads, adrenal cortex, and the corpus luteum, P4 synthesis by placental cells in the 
presence of cAMP soluble derivatives produce no acute response, not even in cells obtained 
from first-trimester placentas (Zosmer et al., 1997).  
Previous data confirm that trophoblast cells have the machinery to produce cAMP, which may 
increase its concentration in cytoplasm through the stimulation of ǃ2 adrenergic receptors in 
full-term placentas (Kasugai et al., 1987). Interestingly, in first-trimester placentas, 
norepinephrine increased the content of cAMP mediated by ǂ1-adrenergic receptors (Shi  
Zhuang, 1993). There is also evidence of the potential effect of other hormones that may 
stimulate placental P4 synthesis through cAMP-dependent pathways, just like it happens in 
the case of estrogens (Pepe  Albretch, 1999), insulin (Lavy et al., 1987), insulin-like growth 
factor 1 (Nestler, 1987) and epidermal growth factor (Ritvos, 1988). The results suggest the 
possibility of different stimuli for specific effectors according to the gestational age. 
The function of PKA in cells is vital, since its activity is aimed at specific functions, which 
include the differential expression of regulatory and catalytic subunits in different tissues. 
Thus, anchor proteins (AKAP’s, A-kinase anchor proteins) in certain cellular locations place 
PKA close to its substrates, making its activity more efficient (Fig. 7). For instance, in Leydig 
tumoral cells from mice the association of AKAP 121 with the regulatory subunit ǂ of PKA 
II in mitochondria in response to cAMP was observed, which was interpreted as a powering 
effect of steroidogenesis on directing the synthesis and activation of StAR to the 
mitochondrion  in response to cAMP (Dyson et al., 2008). 
In a similar way, mitochondria isolated from human placenta show the interaction of PKA, 
AKAP-121, and PTPD1 (Gómez-Concha et al., 2011) (Fig. 8). In addition, it was seen that in 
the presence of radioactive ATP several proteins were phosphorylated in less than 5 min on 
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Fig. 7. A signaling complex made up by AKAP 121, which anchors PKA close to the 
mitochondrion, thus facilitating the phosphorylation of mitochondrial proteins (Modified 
from Feliciello, 2005). 
 
Fig. 8. Immunodetection of PKA (A), AKAP-121 (B) and PTPD1 (C) (see Material and 
Methods from Gómez Concha, 2011.)  
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serine and threonine, and to a lesser degree on tyrosine, suggesting the potential activity of 
kinases. Likewise, the importance of cAMP-PKA pathway in BeWo cells and in mitochondria 
isolated from human placenta was shown using H89, an inhibitor of PKA activity 
(Maldonado-Mercado et al., 2008). In mitochondria isolated from syncytiotrophoblast, 
steroidogenesis was inhibited 50% with 100 µM of H89, whereas in BeWo cells with 
concentrations of 10 and 20 µM, an inhibition of steroidogenesis of 70% and 90% was found, 
respectively. The addition of 22(R)-hydroxycholesterol to the isolated mitochondria previously 
inhibited with H89, reestablishes P4 synthesis, thus confirming that the activities of P450scc 
and 3HSD are not affected by H89. 
The results show that to the maximal concentration of H89 inhibited the synthesis of P4 in 
99%, but only 50% of protein phosphorylation, which suggests that there are other kinase 
activities in mitochondria isolated from the human placenta, suggesting the pathway 
mediated by PKA could be associated to another pathways that ensures the production of 
P4; then it is relevant to determine the kinases that participate and their associations with 
the steroidogenesis by the human placenta as it was proposed (Maldonado-Mercado et al., 
2008; Gómez -Concha et al., 2011) (Fig. 9). 
  
 
Fig. 9. Progesterone syntheses by syncytiotrophoblast mitochondria (A and B) and 
progesterone synthesis in BeWo cells (C and D) (see Material and Methods from 
Maldonado-Mercado et al., 2008, and Gómez-Concha et al., 2011). 22(R)-hydroxycholesterol 
(22-OH-Cholesterol or 22OH-Chol).  
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Interestingly, in cultured human placenta cells, the stimulus of an acute signaling pathway 
associated with steroidogenesis as the one observed in isolated mitochondria has not been 
described; nevertheless it has been suggested that the pathway mediated by PKA/cAMP 
plays an important role in the regulation of placental steroidogenesis, perhaps with the 
potential participation of other signal transduction pathways, as it has been observed in 
other tissues (Dodge-Kafka  Kapiloff, 2006). The endocrine, paracrine, autocrine, and even 
intracrine mechanisms that modulate this process are still to be described. No matter which 
one is the signaling pathway activated, the importance of the events of dynamic 
phosphorylation of proteins with pleiotropic effects in cellular functions as hormonal 
synthesis is the most relevant (Corso  Thomson, 2001; Gorostizaga et al., 2007; Thomson, 
2002). 
4.2 Protein phosphorylation in the control of steroidogenesis 
Protein phosphorylation is one of the most studied postranslational modifications. The 
modification of target proteins on specific residues allows structural changes, changes in the 
protein-protein interaction, and favors their activation or inactivation (Chang & Karin, 
2001), thus achieving the regulation of their functions (Matthews, 1995; Klumpp & 
Krieglstein, 2005; Puttick et al, 2008).  
It has been shown that the activity of certain proteins modulated by phosphorylation/ 
dephosphorylation has a temporary effect in specific cellular regions such as the plasma 
membrane, endoplasmic reticulum, and nucleus, regulating the cellular metabolism (Trost, 
2010; Bauman & Scott, 2002), a system that seems to be associated with steroidogenesis 
(Gómez-Concha et al., 2011), similar to StAR protein (Steroidogenic acute regulatory 
protein) in adrenal glands and gonads. StAR protein phosphorylation mediated by PKA 
stimulates the transport of cholesterol from the cytoplasm into mitochondrial membranes 
(Stocco, 2000; Thomson, 1998; Manna  Stocco, 2005), apparently through a multiprotein 
complex associated to this organelle (Thomson, 2002) (Fig.10). 
It has been suggested that a tyrosine phosphatases is the key for the regulation of StAR and 
the transport of cholesterol, where phosphorylation/dephosphorylation of intermediary 
proteins is fundamental in the regulation of steroids biosynthesis (Cooke et al, 2011). 
Although the placenta does not synthesize StAR protein, data suggest that trophoblast cells 
have a phosphorylation/dephosphorylation system associated with steroidogenesis. 
It has been described that the PKA activity associated with mitochondria is different from 
that of cytoplasm, suggesting a differential regulation according to their subcellular location, 
maybe related to the complex formed by PKA, AKAP 121, and PTPD1 (Feliciello et al, 2001; 
Gómez-Concha et al., 2011). This way, the identification of proteins phosphorylated on their 
serine, tyrosine, and threonine residues suggests that the metabolism of placental 
mitochondria has important kinase activity (Gómez-Concha et al., 2011). 
In BeWo cells and in isolated mitochondria from placenta, the phosphorylated proteins of 
46, 42 and 36 kDa appear to be a potential target of kinases and phosphatases system, 
where the H89 change the balance of phosphorylation/ dephosphorylation between 
proteins of 42 and 36 kDa (Maldonado-Mercado et al., 2008; Gómez-Concha et al., 2011) 
(Fig. 11 and 12). 
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Fig. 10. Propose model for steroidogenic modulation by mitochondrial PKA (Modified from 
Thomson, 2002). 
 
 
Fig. 11. Incorporation of (32P) to syncytiotrophoblast mitochondria proteins (A) and isolated 
mitochondria from BeWo cells in the presence of H89 (B). (see Material and Methods from 
Maldonado-Mercado et al., 2008; Gómez -Concha et al., 2011) 
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Fig. 12. Model proposed for the participation of PKA in steroidogenesis by 
syncytiotrophoblast mitochondria (Modified from Gómez -Concha et al., 2011). 
5. Steroidogenesis 
The transport of cholesterol to mitochondria by proteins is required for steroidogenesis. 
Deep differences between the placenta and adrenal glands have been observed, which are 
tightly associated to the permanent production of progesterone.  
Meanwhile the cellular movement of cholesterol from cytoplasm to different organelles is 
accomplished by StAR, i.e. adrenal glands, gonads, liver, brain and others; human placenta 
does not express the StAR protein. A metastatic lymph node 64 protein (MLN64), which has 
similar characteristics to StAR protein to recognize cholesterol and transport it to the 
mitochondria, has been implicated in the movement of cholesterol in the human placenta; 
also, other proteins have been associated with cholesterol transport, such as the heat shock 
protein 60 (HSP60) (Olvera-Sanchez et al, 2011) and porine (Espinosa-Garcia et al., 2000). 
In the previous sections of this chapter, several aspects of the trophoblast cells have been 
described. As it was observed, the human placenta possesses special characteristics basically 
oriented to maintain the relationship between mother and fetus in order to reach a 
successful delivery. The human placenta works as a mechanical barrier, being highly 
specific about the molecules that can cross it. In a sense, it controls by itself the mechanisms 
that regulate the metabolism and hormone production to assure nutrient supply by using 
different metabolic and signaling pathways, also modulating the mitochondrial activity 
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through ATP-diphosphohydrolase and other enzymatic activities due to the relevant role 
that mitochondria play in both ATP synthesis and steroidogenesis. 
As mentioned before, cholesterol is the source of steroid hormones, but the human placenta 
is unable to synthesize it, so the cholesterol must be obtained from mother´s lipoproteins. 
During pregnancy, the amount of progesterone required is high, and during the first 
trimester its production is responsibility of the corpus luteum, while the egg implantation in 
the maternal epithelium of the uterus occurs. 
5.1 Electron transport chain coupled to cytochrome P450scc 
Placental steroidogenesis is an essential process for reproduction. Syncytiotrophoblast cells are 
the P4-producing cells in the human placenta (Martinez et al., 1997). By full-term pregnancy, 
placenta produces about 300 mg of P4 per day (Strauss et al., 1996). The first enzymatic stage 
in its production is the conversion of cholesterol into P5 by P450scc type I (CYP11A1; EC 
1.14.15.6), composed by approximately 530 amino acids, including the signal peptide 
necessary for its association to the mitochondrial inner membrane and only one heme group. 
P450scc receives six electrons from 3 moles of NADPH through a 54 kDa flavoprotein, 
ferredoxin reductase (adrenodoxin reductase), and ferredoxin (adrenodoxin) a 2Fe-2S protein 
with a molecular weight of 13.5 kDa. Both are found in the mitochondrial matrix. Studies of 
the molecular mechanism about the formation of this complex and electron transport have 
proposed a stoichiometry for proteins 1:1:1 or 1:2:1, and it has been suggested that 
adrenodoxin behaves as a mobile electron transporter from adrenodoxin reductase to P450scc 
(Miller, 2005), and the interaction between CYP11A and adrenodoxin reductase has been 
shown by molecular biology technics (Payne & Hales, 2004; Strushkevicha, 2011) (Fig. 13). 
 
Fig. 13. Electron transport from adrenodoxin reductase to P450scc. Ado = adrenodoxin; Adr 
= Adrenodoxin reduced; FAD = adrenodoxin reductase (Modified from Payne  and Hales, 
2004). 
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The transformation of cholesterol into P5 requires three mono-oxygenation reactions, using 
molecular oxygen, involving two stereo-specific hydroxylations with the formation of 22(R)-
hydroxycholesterol and 20(R),22(R)-dihydroxycholesterol followed by the breaking of the 
bond C-C between carbons 20 and 22 to release the lateral chain, yielding isocaproaldehyde 
and P5, which is changed into P4 through two consecutive reactions that require NAD+ and 
are catalyzed by the same enzyme 3HSD type 1 (EC 5.3.3.1) with no release of 
intermediaries. Two isoenzymes of 3HSD are known in humans, product of different genes 
(Payne & Hales, 2004). In the placenta, 3HSD is found in the mitochondria, unlike other 
steroiodogenic tissues in which it is found in the endoplasmic reticulum. The activity of this 
enzyme is higher than P450scc activity; therefore, it is not a limiting step in P4 synthesis 
(Tuckey, 2005). On the other hand, no disease involving the loss of 3HSD activity in the 
placenta is known, suggesting that its absence is incompatible with pregnancy. 
5.2 Systems for cholesterol transport and mitochondrial contact sites 
The cholesterol that participates in P4 synthesis comes from maternal circulation as 
lipoprotein complexes (LDL or HDL) which bind to their receptors in the plasma membrane. 
LDLs are released from their endosomal receptors to make late endosomes/lysosomes and 
obtain free cholesterol as substrate for P450scc (Hu et al., 2010).  
The transport of cholesterol from the cytoplasm into the outer mitochondrial membrane in 
most steroidogenic tissues is associated to many proteins; the StAR, is the first protein 
identified as part of a family that contains the START domain (StAR-related lipid transfer 
domain) of about 210 amino acids. It is synthesized as a 37 kDa protein with a signal peptide 
aimed to the mitochondrion to yield cholesterol to the outer mitochondrial membrane and, 
then is transformed into a 30 kDa intramitochondrial protein (Manna & Stocco, 2005). This 
protein is phosphorylated and activated in response to hormonal stimulation in 
steroidogenic cells (Arakane et al., 1996). The constructs lacking the 62 amino acid residues 
from the amino-terminal of StAR yields a truncated protein still able to participate in 
steroidogenesis. These results suggest that the translocation of the StAR protein to the 
interior of the mitochondria is not a requisite for cholesterol transport, and suggests that 
cholesterol may be transferred to another soluble acceptor protein or transporter in the outer 
mitochondrial membrane which finally allows it to reach P450scc for P4 synthesis (Bose et 
al., 2000; Alpy & Tomasetto, 2006). Nevertheless, the human placenta does not express StAR, 
and it has been proposed that the protein MLN64 (Moog-Lutz, 1997) could perform the 
activity of cholesterol transporter. MLN64 is a 54 kDa protein (445 amino acids), isolated 
from a metastatic nodule of breast cancer. MLN64 is found in late endosomes and has two 
functional domains, one in the amino end with four transmembrane domains and another at 
the carboxyl end, corresponding to the START domain, oriented towards the cytoplasm, 
composed by 227 amino acids with an identity of 37% of StAR sequence. The tridimensional 
organization of its crystals shows the formation of a hydrophobic tunnel which allows the 
collocation of one molecule of cholesterol. This location supports the theory of MLN64 
substituting StAR in human placenta to promote the flow of cholesterol.  
Full-term human placenta isolated mitochondria synthesize P4 without the addition of 
exogenous cholesterol (Martinez et al., 1997). It has been reported that cholesterol transport 
between human placenta mitochondrial membranes requires proteins, since when treated 
with trypsin they are unable to transport cholesterol and, therefore, synthesize P4. 
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Nevertheless, mitochondria treated with trypsin were able to efficiently transform 22(R)-
hydroxycholesterol into P4, a substrate that does not need a protein membrane transport 
system, showing that the P450scc chain is not modified by such treatment; thus making 
human placenta isolated mitochondria an adequate model for the study of cholesterol 
transport and steroidogenesis (Espinosa-García et al., 2000). 
The transport of cholesterol towards the inner mitochondrial membrane requires many 
proteins associated with the contact sites; these are dynamic structures formed by proteins 
coming from both the outer and inner membrane and work as complexes that are assembled 
and degraded according to specific mitochondria conditions. Hence, contact sites might 
represent the most efficient route for cholesterol to reach P450scc (Thomson, 2003). 
It has been reported that during the isolation of mitochondrial contact sites from full-term 
human placenta, 3 fractions were obtained from the outer membrane and 4 from the inner 
membrane. The protein composition was specific for each one of them and only one fraction 
of the inner membrane was able to transform cholesterol into P4. In such fraction, reported 
as steroidogenic site, porine, creatine kinase, the translocator of adenine nucleotides, ATP-
diphosphohydrolase, MLN64, and HSP90, HSP72, HSP40 and HSP27, enzymes of the 
P450scc chain, and NADP+-dependent isocitrate dehydrogenase were identified. These 
results support the theory that binding sites are an efficient system for cholesterol transit in 
the human placenta mitochondria (Uribe et al., 2003) (Fig. 14). 
 
Fig. 14. Model of isolated contact sites from human placental syncytiotrophoblast 
mitochondria. (Modified from Uribe et al., 2003). 
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The use of MLN64 antibodies allowed the recognition of a 60 KDa protein identified as an 
HSP and another 30 kDa protein corresponding to the START domain of MLN64, in human 
placenta isolated mitochondria. Results suggest that both proteins participate in placental 
seteroidogenesis, favoring both cholesterol movement towards mitochondrial membranes 
and the release of P4 from mitochondria (Olvera-Sanchez et al., 2011).   
5.3 Steroidogenesis regulation 
P4 biosynthesis regulation in placenta seems to be at two levels. One is related to hormones 
and/or factors currently unknown, which initiates a signal transduction cascade involving 
PKA activation cAMP mediated, as explained before, and another level involving the 
mitochondria. 
As for the mechanism at mitochondrial level, it has been proposed that the activity of 
P450scc might be regulated by the concentration of adrenodoxin reductase which causes a 
decrease of P450scc affinity for cholesterol, and makes it work just at 16% of its capacity 
(Tuckey & Headlam, 2002). Nevertheless, the results obtained from mitochondria isolated 
from the placenta in the presence of 22(R)-hydroxycholesterol show no limitation in their 
capacity to produce P4. Therefore, it is unlikely that in physiologic conditions the activity of 
adrenodoxin reductase is a controlling factor. 
Just like other steroidogenic tissues, the limiting step in P4 production is the access of 
cholesterol to mitochondria. So far, no evidence of any protein limiting transport is 
available, surely because it would be incompatible with pregnancy. Data available suggest 
that placental cells have the necessary mechanisms to allow cholesterol to reach 
mitochondria constantly, making P4 synthesis a constitutive metabolic pathway that 
assures, independently of nutritional conditions, physical or related to mother’s health, that 
the fetus reaches the full term of pregnancy. In this context, the knowledge of the endocrine, 
paracrine, etc., signaling pathways would allow the development of therapeutic strategies 
that favor the integral development of the fetus. 
Nevertheless, it is important to mention that acute regulation at mitochondrial level is 
necessarily accompanied by a chronic modulation mediated by the control of the 
transcription/translation of the genes that encode for the different steroidogenic enzymes, 
in a tissue-specific fashion. As for the placenta, it has been observed that there are 
mechanisms controlling the expression of the genes of the steroidogenic enzymes in which 
cAMP has no prominent role. 
In gonads or adrenal glands, mutations of the genes encoding for proteins STARD1, 
CYP11A1 or 3HSD affects steroid production, being SF-1 the main factor regulating P450scc 
expression (Schimmer & White, 2010). Nevertheless, SF-1 factor is not found in human 
placenta. It has been suggested that P450scc expression is regulated by AP-2 factors that 
bind to cis elements overlapped to the sequences required for the recognition of SF-1 in 
other steroidogenic tissues (Ben-Zimra, 2002). It has also been proposed that LBP (Long 
Terminal Repeat Binding Proteins) identified in the syncytiotrophoblast might assume the 
regulator role of SF-1, binding to the region -155 to -131 of the promoter of the genes that 
allow the expression of P450scc. LBP-1b would act as an activator of the expression of 
P450scc, whereas LBP-9 and LBP-32 would act as repressors (Henderson et al., 2008; LaVoie 
& King., 2009). 
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6. Conclusion 
On the whole, the information shows that mitochondria isolated from human placenta are 
an appropriate model to study the mechanisms of cholesterol transport. The physiological 
difference between human placenta and other steroidogenic organs make the human 
syncytiotrophoblast a particular tissue, which maintains a functional independence while 
allowing the interaction between the mother and the fetus to successfully reach the full term 
of pregnancy in order to perpetuate the species. 
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